CAS 1051375-13-3

Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate

CAS : 1051375-13-3

Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate

Formule : C₁₉H₁₆F₂N₃NaO₅

Degré de pureté : 97%

Masse moléculaire : 427.34

Ref: 54-PC1004410

Cabotegravir sodium

CAS : 1051375-13-3

Sodium (3S,11aR)-8-((2,4-difluorobenzyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-olate

Formule : C₁₉H₁₆F₂N₃NaO₅

Degré de pureté : 97%

Masse moléculaire : 427.33

Ref: IN-DG449977

Cabotegravir sodium

CAS : 1051375-13-3

Cabotegravir sodium inhibits HIV integrase (IC50: 2.5 nM), metabolized by UGT1A1, with minimal ARV interaction.

Formule : C₁₉H₁₆F₂N₃NaO₅

Degré de pureté : 99.63%

Couleur et forme : Solid

Masse moléculaire : 427.34

Ref: TM-T62328

Cabotegravir sodium

CAS : 1051375-13-3

Cabotegravir sodium is a peptide that belongs to the class of activators. It is a high-purity reagent that has been shown to inhibit ion channels. Cabotegravir sodium binds to the receptor and inhibits the binding of ligands, which may lead to cell death. This compound has been shown to be an inhibitor of protein interactions and can be used as a research tool in life science, cell biology, pharmacology, and other fields. Cabotegravir sodium is also known as CAS No. 1051375-13-3.

Formule : C₁₉H₁₆F₂N₃O₅•Na

Degré de pureté : Min. 95%

Masse moléculaire : 427.3 g/mol

Ref: 3D-BSB37513